<DOC>
	<DOCNO>NCT01973400</DOCNO>
	<brief_summary>Given tocotrienols show possess neuroprotective effect type 1 type 2 diabetes lead peripheral neuropathy cognitive impairment , present study aim determine beneficial effect tocotrienols ameliorate neurological related event type 1 type 2 diabetic patient .</brief_summary>
	<brief_title>Neuroprotection Tocotrienols Type 1 Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Neuropathy affect approximately 30-50 % diabetic patient commonest form neuropathy develop world . Pain distress symptom neuropathy main factor prompt patient seek medical advice . About 16-26 % diabetes patient experience chronic neuropathic pain . An animal study reveal treat rat α-tocopherol tocotrienol 10 week significantly improve biochemical behavioral outcome alcohol-induced neuropathy dose-dependent manner potent effect observe tocotrienols . The study demonstrate effectiveness tocotrienols attenuation alcoholic neuropathy . Cognitive dysfunction less addressed well recognize complication diabetes . Patients type 1 type 2 diabetes mellitus find cognitive deficit attribute disease . Both old age diabetes independently associate increase risk cognitive dysfunction ; risk even great old adult diabetes . Cognitive Function term use describe person 's state consciousness ( alertness orientation ) , memory , attention span . It suggest Vitamin E , include tocopherol tocotrienols , help improve cognitive function stall cognitive decline antioxidant effect . A reason nutrient 's success prevent oxidative damage brain cell fat-soluble criterion . During World Alzheimer 's Congress hold July 2001 , report high intake vitamin E effectively lessen memory loss cognitive dysfunction among 6,000 elderly subject generally take Vitamin E 200 400 IU per day . Tocotrienols , particular α-tocotrienol show possess neuroprotective effect independent anti-oxidant activity . Using cell-based study , α-tocotrienol α-tocopherol show prevent glutamate-induced neuronal cell death nanomolar concentration . Later study show α-tocotrienol conferred protection glutamate stroke-induced neurodegeneration rat . In view neuroprotective property tocotrienols , researcher proceed demonstrate tocotrienols supplementation help reverse neuropathic pain diabetic rat . It postulate beneficial property tocotrienols due suppressive effect oxidative-nitrosative stress , inflammatory cytokine release caspase-3 implicated pathogenesis diabetic neuropathy . In year , tocotrienols show prevent cognitive deficit attenuate alcoholic peripheral neuropathy associate selective neuronal damage due chronic alcohol consumption . Moreover , beneficial effect find pronounced tocotrienols compare tocopherol . It postulate anti-oxidants property tocotrienols , suppression nitrosative stress elevate cytokine level together acetylcholinesterase activity brain region contribute significantly prevent chronic alcohol-induced cognitive deficit rat . Yuen group currently conduct clinical study human subject neuroprotective effect tocotrienols ( NCT00753532 ) . In study , subject follow 2 year determine volume white matter lesion repeat MRI treatment tocotrienol compare placebo . White matter lesion related vascular event brain represent subclinical infarct , result death/ degeneration neuron positively correlate cognitive impairment . Preliminary result interim analysis encouraging ; patient tocotrienols show significant reduction volume white matter lesion ( confidential communication ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<criteria>Diabetic adult ( type 1 2 ) ≥20 year old diabetic peripheral neuropathy Total Symptom Score ( TSS ) ≥ 3 point . Patients type 1 diabetes ( duration ≥5 year ) . Patients type 2 diabetes ( diagnosis ) . Patients Neuropathy Impairment Score ( NIS ) &gt; 2 Patients HbA1c &gt; 12 % . Patients hypoglycemia conscious impairment time test conduction . Patients exhibit symptoms peripheral vascular disease absence 2 foot pulse foot ( Posterior tibialis , Dorsalis pedis ) Immunocompromised patient . Patients severe visual impairment , history psychosis ; schizophrenia ; bipolar disorder ; current depression brain trauma patient alcohol dependence drug abuse cocaine , heroin , etc . Those lesion propensity bleed ( e.g. , bleed peptic ulcer ) , history hemorrhagic stroke inherit bleed disorder ( e.g. , hemophilia ) patient warfarin . Pregnancy lactation . Patients renal function test 150 umol/L ( serum creatinine ) . Patients liver function test 5 time upper normal range Active infection infectious disease . Other significant uncontrolled medical illness may interfere drug administration interpretation result .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>